Twinrix

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2017
024619992017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Hepatitis B vaccine has been shown to be highly efficient in preventing hepatitis B. However, 5%-10% of individuals… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
BACKGROUND Hepatitis A and B infections are prevalent worldwide and cause significant morbidity and mortality. A combined vaccine… (More)
Is this relevant?
Review
2007
Review
2007
Twinrix is the only licensed vaccine that provides dual protection against infection with hepatitis A virus (HAV) and hepatitis B… (More)
Is this relevant?
2006
2006
Results of registration trial of combination vaccine for prevention of hepatitis A and B are presented. The trial was conducted… (More)
Is this relevant?
2005
2005
We report on a 26-year-old man who presented with severe jaundice and elevated serum liver enzyme activities after having… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2003
Review
2003
Twinrix (GlaxoSmithKline Biologicals, Rixensart, Belgium) is the first combined vaccine to provide protection against both… (More)
Is this relevant?
2001
2001
In an open, randomized, multicenter, controlled clinical trial in the US, 773 adults were administered either a combination… (More)
Is this relevant?
2001
2001
The immunogenicity of three currently used hepatitis B vaccines was compared in an unselected study population in an every day… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2000
2000
Twinrix (SmithKline Beecham Biologicals) is a combined hepatitis A and B vaccine licensed with a three-dose schedule. A two-dose… (More)
Is this relevant?
2000
2000
formation was published in an erratum in the February issue of the Journal [2]. This is an obvious error, because the study… (More)
Is this relevant?